PBE vs. ITEQ ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to BlueStar TA-BIGITech Israel Technology ETF (ITEQ)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$59.85
Average Daily Volume
16,680
30
ITEQ
BlueStar TA-BIGITech Israel Technology ETF
ITEQ Description
The investment seeks to provide investment results that correspond generally to the total return performance of the TASE-BlueStar Israel Global Technology Index™ ("TA-BIGITech™"). The fund will invest at least 80% of its total assets in the component securities of the index and in depositary receipts representing such securities. As a result, normally the fund will invest at least 80% of its total assets in Israeli technology companies. TA-BIGITech™ was created in 2013 by BlueStar Global Investors LLC d/b/a BlueStar Indexes® and the ISE and tracks the performance of exchange-listed Israeli technology operating companies. It is non-diversified.Grade (RS Rating)
Last Trade
$43.99
Average Daily Volume
6,476
34
Performance
| Period | PBE | ITEQ |
|---|---|---|
| 30 Days | -7.22% | -7.88% |
| 60 Days | -7.32% | -7.13% |
| 90 Days | -7.60% | -3.78% |
| 12 Months | -2.23% | 1.69% |
0 Overlapping Holdings
| Symbol | Grade | Weight in PBE | Weight in ITEQ | Overlap |
|---|
PBE Overweight 30 Positions Relative to ITEQ
| Symbol | Grade | Weight | |
|---|---|---|---|
| BMRN | D | 5.44% | |
| NBIX | B | 5.23% | |
| REGN | D | 5.0% | |
| VRTX | C | 4.98% | |
| GILD | F | 4.95% | |
| AMGN | D | 4.93% | |
| TECH | F | 4.91% | |
| BIIB | D | 4.73% | |
| MNKD | C | 3.29% | |
| CPRX | D | 3.21% | |
| EXEL | A | 3.16% | |
| COLL | C | 3.15% | |
| UTHR | A | 3.15% | |
| HALO | D | 3.09% | |
| TGTX | D | 3.06% | |
| CLDX | D | 2.92% | |
| PTCT | F | 2.84% | |
| VCEL | D | 2.83% | |
| DVAX | F | 2.74% | |
| IONS | D | 2.69% | |
| BPMC | B | 2.68% | |
| QGEN | D | 2.66% | |
| ITCI | B | 2.52% | |
| XENE | D | 2.45% | |
| RGEN | D | 2.39% | |
| MYGN | F | 2.34% | |
| FOLD | F | 2.24% | |
| VCYT | F | 2.22% | |
| EYPT | D | 2.21% | |
| ACAD | F | 1.95% |
PBE Underweight 34 Positions Relative to ITEQ
| Symbol | Grade | Weight | |
|---|---|---|---|
| CYBR | C | -8.61% | |
| NICE | D | -8.39% | |
| CHKP | D | -7.85% | |
| DOX | D | -7.18% | |
| WIX | D | -5.74% | |
| MNDY | D | -4.61% | |
| S | C | -4.11% | |
| FROG | C | -3.4% | |
| SEDG | F | -3.18% | |
| GLBE | F | -2.91% | |
| ORA | D | -2.56% | |
| INMD | F | -1.52% | |
| SPNS | A | -1.05% | |
| LMND | B | -0.88% | |
| FVRR | D | -0.79% | |
| CLBT | C | -0.77% | |
| KRNT | F | -0.76% | |
| NNOX | D | -0.76% | |
| NNDM | F | -0.72% | |
| NVCR | F | -0.71% | |
| SSYS | F | -0.64% | |
| RSKD | C | -0.63% | |
| PLTK | D | -0.62% | |
| URGN | F | -0.59% | |
| NGMS | A | -0.56% | |
| RDWR | C | -0.55% | |
| VPG | C | -0.52% | |
| CGNT | C | -0.52% | |
| CEVA | D | -0.48% | |
| MGIC | B | -0.44% | |
| AUDC | F | -0.34% | |
| WKME | F | -0.33% | |
| INVZ | F | -0.28% | |
| LPSN | F | -0.08% |
PBE: Top Represented Industries & Keywords
ITEQ: Top Represented Industries & Keywords
Compare ETFs
